Breast Implant-Associated Anaplastic Large Cell Lymphoma: An Update
Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a T-cell lymphoma, that arises around breast implants and is considered a provisional entity in the 2016 revision of the World Health Organization (WHO) Classification of Tumors of Hematopoietic and Lymphoid Tissues.1 Most patients present with an effusion around the breast implant, with the lymphoma cells usually confined by the capsule around the implant and most patients are cured by removal of the implants and complete excision of the capsule.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Roberto N. Miranda Source Type: research
More News: Breast Augmentation | International Medicine & Public Health | Leukemia | Lymphoma | Myeloma | Plastic Surgery | T-cell Lymphoma | WHO